How to buy iBio shares | $1.53

Own iBio shares in just a few minutes. Share price changes are updated daily.

iBio, Inc (IBIO) is a leading biotechnology business based in the US. It opened the day at $1.52 after a previous close of $1.54. During the day the price has varied from a low of $1.5 to a high of $1.56. The latest price was $1.53 (25 minute delay). iBio is listed on the NYSE MKT and employs 43 staff. All prices are listed in US Dollars.

How has coronavirus impacted iBio's share price?

Since the stock market crash that started in February 2020, iBio's share price has had significant positive movement.

Its last market close was $1.4, which is 78.64% up on its pre-crash value of $0.299 and 453.58% up on the lowest point reached during the March 2020 crash when the shares fell as low as $0.2529.

If you had bought $1,000 worth of iBio shares at the start of February 2020, those shares would have been worth $4,558.82 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $5,147.06.

iBio share price

Use our graph to track the performance of IBIO stocks over time.

iBio shares at a glance

Information last updated 2021-06-18.
Open$1.52
High$1.56
Low$1.5
Close$1.53
Previous close$1.54
Change $-0.01
Change % -0.6494%
Volume 2,791,102
Information last updated 2021-06-17.
52-week range$1.03 - $7.45
50-day moving average $1.4717
200-day moving average $1.5452
Wall St. target price$2.5
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.943
Promoted
eToro Free Stocks

Invest in iBio shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Name Product Ratings Finder rating Customer rating Min. initial deposit Price per trade Frequent trader rate Platform fee Offer Link
Hargreaves Lansdown Fund and Share Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£1
£11.95
£5.95
£0

Capital at risk

Platform details
FREE TRADES
eToro Free Stocks
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
$200
£0
N/A
£0

Capital at risk

Platform details
FREE TRADES
Stake
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£50
US: £0
N/A
£0
Join and receive a free share worth up to £100

Capital at risk

Platform details
Degiro Share Dealing
Finder score
★★★★★
★★★★★
Expert analysis
Not yet rated
£0.01
UK: £1.75 + 0.014% (max £5)
US: €0.50 + $0.004 per share
N/A
£0

Capital at risk

Platform details
interactive investor Trading Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£0
£7.99 (with one free trade per month)
N/A
£9.99 per month

Capital at risk

Platform details
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy iBio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

iBio price performance over time

Historical closes compared with the last close of $1.53

1 month (2021-05-19) 11.68%
3 months (2021-03-19) -11.05%
6 months (2020-12-18) 33.04%
1 year (2020-06-19) 4.08%
2 years (2019-06-19) 86.59%
3 years (2018-06-19) 41.67%
5 years (2016-06-17) -77.72%

Financials

Revenue TTM $3 million
Gross profit TTM $1.6 million
Return on assets TTM -16.63%
Return on equity TTM -49.39%
Profit margin 0%
Book value $0.485
Market capitalisation $340.9 million

TTM: trailing 12 months

How to short and sell iBio shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "IBIO.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 19.9 million iBio shares held short by investors – that's known as the "short interest". This figure is 15.4% up from 17.3 million last month.

There are a few different ways that this level of interest in shorting iBio shares can be evaluated.

Short interest ratio (SIR)

iBio's "short interest ratio" (SIR) is the quantity of iBio shares currently shorted divided by the average quantity of iBio shares traded daily (recently around 15.7 million). iBio's SIR currently stands at 1.27. In other words for every 100,000 iBio shares traded daily on the market, roughly 1270 shares are currently held short.

However iBio's short interest can also be evaluated against the total number of iBio shares, or, against the total number of tradable iBio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case iBio's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 iBio shares in existence, roughly 90 shares are currently held short) or 0.0917% of the tradable shares (for every 100,000 tradable iBio shares, roughly 92 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against iBio.

Find out more about how you can short iBio stock.

iBio share dividends

We're not expecting iBio to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have iBio's shares ever split?

iBio's shares were split on a 1:10 basis on 11 June 2018. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your iBio shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for iBio shares which in turn could have impacted iBio's share price.

Share price volatility

Over the last 12 months, iBio's shares have ranged in value from as little as $1.03 up to $7.45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while iBio's is -6.2158. This would suggest that iBio's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, iBio has bucked the trend.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site